Update on protozoan parasites of the intestine

Andrea N Davis1, Rashidul Haque, William A Petri

  • 1Department of Medicine, University of Virginia Health Sciences System, Charlottesville, Virginia 22908, USA.

Insights

Recent advances in diagnosing and treating gastrointestinal protozoal infections show mixed results. New outbreaks of cyclosporiasis and cryptosporidiosis occurred, but progress was made in understanding pathogenesis and developing vaccines.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Parasitology

Background:

  • Gastrointestinal protozoal infections pose a significant global health challenge.
  • Recent outbreaks of cyclosporiasis and cryptosporidiosis highlight ongoing public health concerns.
  • Existing treatments for some protozoal infections remain limited, necessitating new therapeutic strategies.

Purpose of the Study:

  • To review recent developments in the diagnosis, treatment, and prevention of gastrointestinal protozoal infections.
  • To highlight advances in understanding the pathogenesis of cryptosporidiosis.
  • To explore new therapeutic leads for cryptosporidiosis and giardiasis, and potential vaccine development for amebiasis.

Main Methods:

  • Literature review of recent studies on protozoal gastrointestinal infections.
  • Analysis of outbreak data for cyclosporiasis and cryptosporidiosis.
  • Evaluation of treatment efficacy studies for cryptosporidiosis and giardiasis.
  • Review of research on amebiasis pathogenesis and immunity.

Main Results:

  • New outbreaks of cyclosporiasis and cryptosporidiosis occurred in North America.
  • Paromomycin demonstrated ineffectiveness in treating cryptosporidiosis.
  • Advances were made in diagnosing amebiasis and giardiasis, and in understanding cryptosporidiosis pathogenesis.
  • Potential new treatments for cryptosporidiosis and refractory giardiasis were identified.
  • Evidence of acquired mucosal immunity to amebiasis in children suggests vaccine development is feasible.

Conclusions:

  • Despite challenges like new outbreaks and treatment failures, significant progress has been made in understanding and managing gastrointestinal protozoal infections.
  • Research into pathogenesis and immunity is paving the way for improved diagnostics and novel interventions, including vaccines.
  • Continued research is crucial to address the worldwide impact of these parasitic diseases.

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Overview of Protists01:27

Overview of Protists

Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...